BETHEL, Conn.--(BUSINESS WIRE)--Memry Corporation (AMEX:MRY), a leading provider of nitinol and polymer components to the medical device industry, said today that Noble Financial Group has initiated coverage on Memry with a “buy” recommendation and a price target of $2.50.
